97142 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions
#2MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS
#3VACCINE INCLUDING NONENCAPSULATED STRAIN AS ANTIGEN
#4OFF THE SHELF PROXIMITY BIOTINYLATION ENZYME
#5Human Monoclonal Antibodies Specific to Streptolysin O and Methods of Use
#6LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNS
#7STREPTOCOCCUS PNEUMONIAE SEROTYPE-SPECIFIC DETECTION ASSAY, REAGENTS AND KITS
#8ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION
#9SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#10ANTIGEN-BINDING PROTEIN TARGETING PNEUMOLYSIN AND USE THEREOF
#11HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS
#12Peptides and antibodies for the removal of biofilms
#13COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#14ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN
#15STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
#16GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
#17MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS
#18ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#19Human Streptococcus Pneumoniae Antibodies and Uses Therefor
#20Compositions and methods for the treatment of immunodeficiency
#21VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
#22Binding moieties for biofilm remediation
#23Recombinant Polyclonal Proteins and Methods of Use Thereof
#24antiserum without cross-reactivity and method for producing the same
#25mRNA, episomal and genomic integrated lentiviral and gammaretroviral vector expression of dimeric immunoglobulin A and polymeric immunoglobulin A to Enable Mucosal and Hematological Based Immunity/Protection via Gene Therapy for Allergens, viruses, HIV, bacteria, pneumonia, infections, pathology associated proteins, systemic pathologies, cancer, toxins and unnatural viruses. CAR engineered and non-CAR engineered immune cell expression of dimeric immunoglobulin A and polymeric immunoglobulin A.
#26Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#27STREPTOCOCCAL TOXIC SHOCK SYNDROME
#28Peptides and antibodies for the removal of biofilms
#29Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
#30Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#31GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
#32SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#33Compositions and methods for the treatment of immunodeficiency
#34Vaccine composition against infection
#35Libraries of genetic packages comprising novel HC CDR3 designs
#36BINDING MOLECULES TARGETING PATHOGENS
#37Modified streptolysin O
#38Binding moieties for biofilm remediation
#39Truncated CRISPR-Cas proteins for DNA targeting
#40vaccine
#41Microparticles from as vaccine antigens
#42Group A streptococcus vaccine
#43Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#44Treatment and/or prevention of sepsis
#45Method for purifying antibody or antibody fragment containing κ-chain variable region
#46Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#47Method for treating infection of group A
#48Binding moieties for biofilm remediation
#49Peptides and antibodies for the removal of biofilms
#50IgG, IgA and IgM antibody preparations, method of making and method of use in treatment
#51HU specific interfering agents
#52Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#53Compositions and methods for the treatment of immunodeficiency
#54Libraries of genetic packages comprising novel HC CDR3 designs
#55Pneumococcal serotypes
#56BINDING MOLECULES TARGETING PATHOGENS
#57Nucleic acids and proteins from streptococcus groups A and B
#58Compositions and methods for the treatment of immunodeficiency
#59Method of inhibiting microglial cell migration and treating traumatic brain injury
#60Monoclonal antibody against muramyl peptides
#61Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#62VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
#63Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#64Xenoantigen-displaying anti-cancer vaccines and method of making
#65Antibody preparations
#66Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#67Rapid detection of the “high virulent” ST-17 clone of group B
#68Group A vaccine
#69Nebultzation of immunoglobulin
#70Process and materials for the rapid detection of employing purified antigen-specific antibodies
#71Immunogenic proteins and compositions
#72Compositions containing antimicrobial IgY antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (OHC) microorganisms
#73Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#74Fab region-binding peptide
#75Nucleic acids and proteins from streptococcus groups A and B
#76Binding moieties for biofilm remediation
#77Human antibodies and uses therefor
#78Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#79Compositions and methods for the treatment of immunodeficiency
#80Compositions and methods for the treatment of immunodeficiency
#81Vaccine against streptococcal infections based on recombinant proteins
#82POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE
#83Monoclonal antibodies to anthrax protective antigen
#84Modified pneumolysin (PLY) polypeptides
#85Nucleic acids and proteins from groups A and B
#86Monoclonal antibody against muramyl peptides
#87Immunogenic proteins and compositions
#88Carbohydrate-glycolipid conjugate vaccines
#89Process and materials for the rapid detection of employing purified antigen-specific antibodies
#90Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#91BINDING MOLECULES TARGETING PATHOGENS
#92Compositions and Methods for the Removal of Biofilms
#93Antibody preparations
#94GAS57 mutant antigens and GAS57 antibodies
#95Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#96Modified pneumonia pneumolysin (PLY) polypeptides
#97Method of detecting the presence of an antibody in a sample
#98Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
#99Method of detecting the presence of pneumococcal neuraminidases in -infected samples
#100METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL SURFACE AND PHAGOCYTOSIS BY PHAGOCYTE AND A THERAPEUTIC METHOD AND A THERAPEUTIC AGENT FOR BACTERIAL INFECTIONS
#101Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#102Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis
#103Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease
#104antigens I and II
#105Pneumococcal serotypes
#106Vaccine against streptococcal infections based on recombinant proteins
#107Pneumococcal Serotype 6D
#108GAS57 mutant antigens and GAS57 antibodies
#109Human antibodies and uses therefor
#110IMMUNOGENIC COMPOSITIONS
#111Group B polypeptides, nucleic acids and therapeutic compositions and vaccines thereof
#112Immunogenic proteins and compositions for the treatment and prevention of
#113Process for preparing an immunoglobulin composition
#114Antibody preparations
#115Nucleic acids encoding GAS57 mutant antigens
#116Method for selecting and producing vaccine components and vaccines based thereon
#117Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#118RECOMBINANT PROTECTIVE PROTEIN FROM STREPTOCOCCUS PNEUMONIAE
#119Modified pneumolysin (PLY) polypeptides
#120PURIFICATION OF BACTERIAL ANTIGENS
#121Compositions and methods for the removal of biofilms
#122PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
#123Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
#124antigens I and II
#125Libraries of genetic packages comprising novel HC CDR3 designs
#126GAS57 mutant antigens and GAS57 antibodies
#127Antigenic protein fragments of
#128Therapeutic Antibodies, Antibody Fragments And Antibody Conjugates
#129PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES
#130Method for detection of pneumococcus
#131Anti-bacterial antibodies
#132PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
#133Immunogenic polypeptides and monoclonal antibodies
#134METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE AND PATHOGENIC DISEASES
#135STREPTOCOCCUS PNEUMONIAE VACCINES
#136antigens
#137Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#138Pneumococcal serotype 6D
#139Group B polypeptides nucleic acids and therapeutic compositions and vaccines thereof
#140ANTI-MICROBIAL TARGETING CHIMERIC PHARMACEUTICAL
#141AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AND METHODS OF MAKING AND USING THEM
#142Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker
#143COMBINATION GAS VACCINES AND THERAPEUTICS
#144Protective proteins of , combinations thereof and methods of using the same
#145Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease
#146METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#147Nucleic acids and proteins from groups A & B
#148Fusion Proteins Comprising Two or More IgG Binding Domains of Streptococcal Protein G
#149PURIFICATION OF BACTERIAL ANTIGENS
#150Monoclonal antibodies to anthrax protective antigen
#151Anti-antibodies
#152ANTIBODIES FOR DETECTING MICROORGANISMS
#153Novel Tannase Gene And Protein Thereof
#154polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
#155BINDING MEMBER TOWARDS PNEUMOLYSIN
#156Composition and method for treating infection
#157Non-coiled protective regions of pneumococcal surface proteins PspA and PspC
#158Rapid detection of the “high-virulent” ST-17 clone of group B
#159SYNTHETIC CHIMERIC PEPTIDES
#160antigens I and II
#161Method for preparing immunoglobulin libraries
#162Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates
#163ADHERENCE INHIBITOR DIRECTED TO AND METHOD OF MAKING AND USING
#164Method of passive immunization
#165Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
#166NANOPARTICLE ADJUVANTS FOR SUB-UNIT VACCINES
#167Vaccine for periodontitis and methods of use
#168Antibody diversity generation
#169Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#170Immunoassay Method and Immunoassay Kit to Be Used Therein
#171Mutant pneumolysin proteins
#172Compounds
#173Methods and compositions for diagnosing and preventing a group B streptococcal infection
#174Purification of bacterial antigens
#175Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
#176Compositions for reducing bacterial carriage and CNS invasion and methods of using same
#177Process and Materials for the Rapid Detection of Streptococcus Pneumoniae Employing Purified Antigen-Specific Antibodies
#178Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
#179Diabody which specifically binds surface antigen I/II and methods of use thereof
#180Recombinant protective protein from
#181Recombinant protective protein from
#182Treatment of infections utilizing antibodies that bind to fibronectin binding proteins
#183Streptococcal streptolysin S vaccines
#184Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#185Method for selecting and producing vaccine components and vaccines based thereon
#186Antibodies and methods for predicting dental caries
#187Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs
#188Binding member towards pneumococcus surface adhesin a protein (psaa)
#189antigens I + II
#190Nucleic acids and proteins from groups A and B
#191Human antipneumococcal antibodies from non-human animals
#192Pneumolysin derivatives
#193Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#194Nucleic acids and proteins from groups A and B
#195Nucleic acids and proteins from groups A & B
#196Nucleic acids and proteins from groups A and B
#197Nucleic acids and proteins from streptococcus groups A & B
#198Streptoccal inhibitor of complement-mediated lysis, protein SIC
#199Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy
#200Streptococcus pyogene antigens
#201Immunization of non-human mammals against
#202Compounds
#203Group a streptococci bind to mucin and human pharyngeal cells through a sialic acid-containing receptor
#204Transgenic plants expressing assembled secretory antibodies
#205Antibodies to the FbsA protein of streptococcus agalactiae and their use in treating or preventing infections
#206Collagen-binding proteins from enterococcal bacteria
#207Process and materials for the rapid detection of Streptococcus pneumoniae employing purified antigen-specific antibodies
#208Fibronectin binding protein compositions and methods of use
#209Antibody diversity generation
#210Glucan binding protein and glucosyltransferase immunogens
#211Glucosyltransferase immunogens
#212Human antipneumococcal antibodies from non-human animals
#213antigens and vaccines
#214antigens associated with strains virulent in fish